Take home message In Phase 3 trials, retatrutide has produced higher weight loss than Wegovy: 28.7% at 68 weeks on the 12 mg dose, compared with 20.7% at 72 weeks on the newer Wegovy 7.2 mg dose, and 14.9% at 68 weeks on the older 2.4 mg dose
Working with a professional ensures your plan is tailored specifically to your bodys needs, your health goals, and your unique response to the treatment
Patients sometimes assume the medication will be unaffordable, sometimes assume it will be cheap
Before starting, it is wise to ask: Can I sustain this medication if it works
Water, Milk, or Other Liquid Youll need water or something else to cook or soak your oats in
At 104 weeks (2 years), patients in this subgroup reached 30.3% average weight loss confirming that retatrutide doesn't plateau at the primary endpoint and continues to improve with extended treatment